Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 57,254 | 53,697 | 55,259 | 55,595 | 75,798 |
| Operating Income | -57,254 | -53,697 | -55,259 | -55,595 | -75,798 |
| Other Income | 3,550 | 4,036 | 4,546 | 4,985 | 5,743 |
| Pre-tax Income | -53,704 | -49,661 | -50,713 | -50,610 | -70,055 |
| Net Income Continuous | -53,704 | -49,661 | -50,713 | -50,610 | -70,055 |
| Net Income | $-53,704 | $-49,661 | $-50,713 | $-50,610 | $-70,055 |
| EPS Basic Total Ops | -0.81 | -0.75 | -0.78 | -0.77 | -1.07 |
| EPS Basic Continuous Ops | -0.87 | -0.82 | -0.86 | -0.86 | -1.19 |
| EPS Diluted Total Ops | -0.81 | -0.75 | -0.78 | -0.77 | -1.07 |
| EPS Diluted Continuous Ops | -0.87 | -0.82 | -0.86 | -0.86 | -1.19 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.75 | -0.77 | -0.77 | -1.07 |
| EBITDA(a) | $-57,175 | $-53,618 | $-55,180 | $-55,516 | $-75,721 |